Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


01 enero 2017

JACC: CARDIOVASCULAR INTERVENTIONS. The ReACT Trial: Randomized Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial

Hiroki Shiomi, Takeshi Morimoto, Shoji Kitaguchi, Yoshihisa Nakagawa, Katsuhisa Ishii, Yoshisumi Haruna, Itaru Takamisawa, Makoto Motooka, Kazuhiro Nakao, Shintaro Matsuda, Satoru Mimoto, Yutaka Aoyama, Teruki Takeda, Koichiro Murata, Masaharu Akao, Tsukasa Inada, Hiroshi Eizawa, Eiji Hyakuna, Kojiro Awano, Manabu Shirotani, Yutaka Furukawa, Kazushige Kadota, Katsumi Miyauchi, Masaru Tanaka, Yuichi Noguchi, Sunao Nakamura, Satoshi Yasuda, Shunichi Miyazaki, Hiroyuki Daida, Kazuo Kimura, Yuji Ikari, Haruo Hirayama, Tetsuya Sumiyoshi, Takeshi Kimura, ReACT Investigators, Kazuo Kimura, Kiyoshi Hibi, Katsuhisa Ishii, Kazuaki Kataoka, Takeshi Kimura, Hiroki Shiomi, Manabu Shirotani, Shunichi Miyazaki, Teruki Takeda, Satoshi Yasuda, Kazuhiro Nakao, Masaharu Akao, Mitsuru Ishii, Eiji Momona, Tetsuya Sumiyoshi, Itaru Takamisawa, Hiroyuki Daida, Katsumi Miyauchi, Satoru Mimoto, Sunao Nakamura, Yutaka Furukawa, Shintaro Matsuda, Hiroshi Eizawa, Akinori Takizawa, Koichiro Murata, Masaru Tanaka, Tsukasa Inada, Yuichi Noguchi, Yoshihisa Nakagawa, Makoto Motooka, Yuji Ikari, Kojiro Awano, Yoshisumi Haruna, Shoji Kitaguchi, Haruo Hirayama and Mamoru Nanasato

Objectives: The purpose of this study was to evaluate long-term clinical impact of routine follow-up coronary angiography (FUCAG) after percutaneous coronary intervention (PCI) in daily clinical practice in Japan.

01 enero 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Randomized Comparison of Oral P2Y12-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor

Willibald Hochholzer, Pascal Kleiner, Iris Younas, Christian M. Valina, Nikolaus Löffelhardt, Michael Amann, Timo Bömicke, Miroslaw Ferenc, Dieter Hauschke, Dietmar Trenk, Franz-Josef Neumann and Christian Stratz

Objectives: This randomized trial tested whether early loading with prasugrel can provide sufficient platelet inhibition even when given at the start of a 2-h infusion of cangrelor.

01 enero 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions

Koen Teeuwen, René J. van der Schaaf, Tom Adriaenssens, Jacques J. Koolen, Pieter C. Smits, José P.S. Henriques, Paul H.M.J. Vermeersch, R. Melvyn Tjon Joe Gin, Bastiaan E. Schölzel, Johannes C. Kelder, Jan G.P. Tijssen, Pierfrancesco Agostoni and Maarten J. Suttorp

Objectives: The aim of this study was to investigate the efficacy and safety of the hybrid ultrathin-strut sirolimus-eluting stent (SES) with biodegradable polymer compared with the thin-strut everolimus-eluting stent (EES) with durable polymer in successfully recanalized chronic total occlusions (CTOs).

01 enero 2017

JACC: CARDIOVASCULAR INTERVENTIONS. First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution Study

Stephen G. Worthley, Alexandre Abizaid, Ajay J. Kirtane, Daniel I. Simon, Stephan Windecker, Sandeep Brar, Ian T. Meredith, Sharad Shetty, Ajay Sinhal, Alexandra Popma Almonacid, Daniel Chamié, Akiko Maehara, Gregg W. Stone, RevElution Investigators, Stephen Worthley, Sharad Shetty, Ajay Sinhal, Ian Meredith, Alexandre Abizaid, Nigel Jepson, Ravinay Bhindi, Soo Teik Lim, Peter Stewart, Peter Barlis, Darren Walters, David Muller, Stephen Cox and Rohan Bhagwandeen

Objectives: This study sought to assess the safety and effectiveness of the drug-filled stent (DFS) (Medtronic, Santa Rosa, California) in the treatment of patients with coronary artery disease.

01 enero 2017

JACC: CARDIOVASCULAR INTERVENTIONS. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System

Donald E. Cutlip, Kirk N. Garratt, Victor Novack, Mark Barakat, Perwaiz Meraj, Luc Maillard, Andrejs Erglis, Rajiv Jauhar, Jeffrey J. Popma, Robert Stoler, Sigmund Silber, PzF SHIELD Trial Investigators, Donald Cutlip, Suhail Allaqaband, Ronald Caputo, Nirat Beohar, David Brown, Kirk Garratt, Rajiv Jauhar, Jon George, Vincent Varghese, Mark Huth, German Larrain, Tommy Lee, Amir Malik, Scott Martin, Thomas McGarry, Charles Phillips, Alpesh Shah, Robert Stoler, Michael Ball, R. Jeffrey Price, Joseph Rossi, Charles Taylor, Thaddeus Tolleson, William Nicholson, Srinivas Kesanakurthy, Mohammad Shoukfeh, Aloke Finn, Chandanreddy Devireddy, Charles Shoultz, Mark Robbins, Radoslaw Kiesz, Pramod Menon, Daniel Weilenmann, Horst Sievert, Andrejs Erglis, Goran Stankovic, Jacques Berland, Nicolas Delarche, Jean Lou Hirsch, Luc Maillard, John Shayne, Antonio Serra, Antonio Fernandez-Ortiz, Jean-Pierre Monassier and Sigmund Silber

Objectives: The aim of this study was to assess the safety and effectiveness of the COBRA Polyzene-F NanoCoated Coronary Stent System (CeloNova Biosciences, San Antonio, Texas) for the treatment of de novo coronary artery lesions.

01 enero 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Left Atrial Appendage Thrombus in Transcatheter Aortic Valve Replacement: Incidence, Clinical Impact, and the Role of Cardiac Computed Tomography

Sonny Palmer, Nicholas Child, Mark A. de Belder, Douglas F. Muir and Paul Williams

Objectives: The aim of this study was to describe the incidence and clinical impact of left atrial appendage thrombus (LAAT) in a population referred for transcatheter aortic valve replacement (TAVR) and to examine the role of cardiac computed tomography (CCT) in the diagnosis of LAAT.

01 abril 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials

Ernest Spitzer, Ton de Vries, Rafael Cavalcante, Marieke Tuinman, Tessa Rademaker-Havinga, Maaike Alkema, Marie-Angele Morel, Osama I. Soliman, Yoshinobu Onuma, Gerrit-Anne van Es, Jan G.P. Tijssen, Eugene McFadden and Patrick W. Serruys

Objectives: This study sought to investigate the differences in detecting (e.g., triggering) periprocedural myocardial infarction (PMI) among 3 current definitions.

01 abril 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR

Jacob A. Doll, Dadi Dai, Matthew T. Roe, John C. Messenger, Matthew W. Sherwood, Abhiram Prasad, Ehtisham Mahmud, John S. Rumsfeld, Tracy Y. Wang, Eric D. Peterson and Sunil V. Rao

Objectives: This study sought to determine variability and stability in risk-standardized mortality rates (RSMR) of percutaneous coronary intervention (PCI) operators meeting minimum case volume standards and identify differences in case mix and practice patterns that may account for RSMR variability.

01 abril 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Clinical Bioprosthetic Heart Valve Thrombosis After Transcatheter Aortic Valve Replacement: Incidence, Characteristics, and Treatment Outcomes

John Jose, Dmitriy S. Sulimov, Mohamed El-Mawardy, Takao Sato, Abdelhakim Allali, Erik W. Holy, Björn Becker, Martin Landt, Julia Kebernik, Bettina Schwarz, Gert Richardt and Mohamed Abdel-Wahab

Objectives: The aim of this study was to determine the incidence, characteristics, and treatment outcomes of patients diagnosed with clinical transcatheter heart valve thrombosis.

01 abril 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Tricuspid Regurgitation Does Not Impact Right Ventricular Remodeling After Percutaneous Pulmonary Valve Implantation

Daniel Tanase, Peter Ewert, Stanimir Georgiev, Christian Meierhofer, Jelena Pabst von Ohain, Doff B. McElhinney, Alfred Hager, Andreas Kühn and Andreas Eicken

Objectives: This study sought to investigate the impact of tricuspid regurgitation (TR) on right ventricular function after percutaneous pulmonary valve implantation (PPVI).

01 marzo 2017

JACC: CARDIOVASCULAR INTERVENTIONS. Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore Access: A Multicenter Prospective Study

Nicolas M. Van Mieghem, Azeem Latib, Jan van der Heyden, Lennart van Gils, Joost Daemen, Todd Sorzano, Jurgen Ligthart, Karin Witberg, Thom de Kroon, Nathaniel Maor, Antonio Mangieri, Matteo Montorfano, Peter P. de Jaegere, Antonio Colombo and Gary Roubin

Objectives: The authors sought to study the safety and efficacy of the MANTA Vascular Closure Device (VCD), a novel collagen-based technology dedicated to closure of large-bore arteriotomies.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.